The Personalization of Chemotherapy Using Phenotypic High Content Screening


The current focus in cancer research is to personalize chemotherapy by using biomarkers and genotyping. Another approach, which is currently out of favour, is to measure cell death directly. We believe this second approach has utility at helping get the right drug to the right patient and we present data obtained from both ovarian and glioblastoma patients showing distinct dose response curves to many chemotherapies. While this work has obvious clinical applications, another benefit is that it may help large pharma optimize clinical trials by enriching the study population for patients that will respond to their research compound.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021